Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can

Janardhan Sampath1, Pandy R Long, Robert L Shepard

  • 1Cancer Research Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

Insights

Scientists identified SPF45, a spliceosome component, as a factor in cancer drug resistance. Overexpression of SPF45 in tumors and cell lines correlated with resistance to common chemotherapy drugs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cyclophosphamide resistance in EMT6 mouse mammary tumors prompted the search for novel drug-resistant genes.
  • SPF45 was concurrently identified by other researchers as a spliceosome component involved in alternative splicing.

Purpose of the Study:

  • To investigate the role of SPF45 in cancer drug resistance.
  • To examine the expression pattern of human SPF45 in normal and cancerous tissues.
  • To determine the phenotypic effects of SPF45 overexpression in cancer cells.

Main Methods:

  • Identification of SPF45 in drug-resistant mouse tumors.
  • Isolation and analysis of the human SPF45 homologue.
  • Assessment of SPF45 expression in normal human tissues and various carcinomas using tissue microarrays.
  • Overexpression studies of SPF45 in HeLa cervical carcinoma cells.

Main Results:

  • SPF45 is expressed in various normal human tissues, notably ductal epithelial cells of the breast, liver, pancreas, and prostate.
  • High SPF45 expression was observed in multiple carcinomas, including bladder, breast, colon, lung, ovarian, pancreatic, and prostate cancers.
  • Overexpression of SPF45 in HeLa cells conferred resistance to doxorubicin and vincristine chemotherapy.

Conclusions:

  • SPF45 is a frequently overexpressed splicing factor in numerous human carcinomas.
  • Tumor overexpression of SPF45 is linked to acquired resistance to common chemotherapeutic agents.
  • This study presents the first evidence of an alternative splicing factor contributing to tumor drug resistance.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...